Abstract:The aim of this study was to develop and test an optimal vaccination strategy against bovine viral diarrhea virus (BVDV) based on the E2 glycoprotein of the BJ1305 strain. To achieve higher E2-specific antibody titers and to broaden the cellular immune response, a plasmid encoding the E2 protein (pcDNA3.1-E2) was constructed and a purified recombinant E2 protein was generated. The E2 protein was emulsified in the adjuvant ISA 61 VG prior to administration. We immunized mice three times with pcDNA3.1-E2 or the recombinant E2 protein or primed twice with pcDNA3.1-E2 and boosted once with the E2 protein. To evaluate the protection against BVDV conferred by the vaccines, the mice were challenged with BVDV strain Oregon C24V after the third immunization. Although all immunized mice developed humoral and cellular immune responses, the E2-specific antibody titers in the DNA prime-protein boost group were significantly higher than those elicited by either the DNA or the protein vaccine. In addition, vaccination with the E2 DNA vaccine induced higher percentages of CD4(+)IFN-gamma(+) T cells and CD8(+)IFN-gamma(+) T cells among total CD3(+) T cells than the other regimens. The predominant antibody subclass in the vaccinated mice was IgG1. Serum tumor necrosis factor alpha (TNE-alpha) levels in the DNA prime-protein boost group were significantly higher after the third immunization than in the other groups. Moreover, the mice treated with the DNA prime-protein boost vaccination regimen acquired protection against BVDV challenge, as shown by a significant reduction of viremia, only minor pathological changes, and a lower viral antigen burden than in the control and solo vaccinated mice. These results demonstrate the potential advantage of a DNA prime-protein boost vaccination approach over a solo vaccination for the prevention of BVDV. The ability of this vaccine strategy to control and eradicate BVD in herds warrants further investigation. (C) 2018 Elsevier Ltd. All rights reserved.

Immunogenicity of Recombinant BCGs Expressing Predicted Antigenic Epitopes of Bovine Viral Diarrhea Virus E2 Gene

Immunogenicity validation of recombinant BCG expressing optimized E2 gene of bovine viral diarrhea disease virus

Immunogenicity evaluation of recombinant<i>Lactobacillus casei</i>W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant

Cloning and Optimizing Expression of E2 Gene of Bovine Viral Diarrhea-mucosal Disease Virus in BCG

Recombinant Bcg Coexpressing Ag85b, Esat-6 and Rv3620c Elicits Specific Th1 Immune Responses in C57bl/6 Mice

Novel Recombinant Bcg Coexpressing Ag85b, Esat-6 And Rv2608 Elicits Significantly Enhanced Cellular Immune And Antibody Responses In C57bl/6 Mice

Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant

Expressing of Bovine Viral Diarrhea-Mucosal Disease Virus Changchun184 Strain of E2 Gene in BCG

Evaluation of a Recombinant BCG Expressing Antigen Ag85B and PPE Protein Rv3425 from DNA Segment RD11 of Mycobacterium Tuberculosis in C57BL/6 Mice

Immune Responses and Protective Efficacy Induced by 85B Antigen and Early Secreted Antigenic Target-6 Kda Antigen Fusion Protein Secreted by Recombinant Bacille Calmette-Guérin

Protective Immunity of Recombinant Mycobacterium Bovis BCG Expressing Rhomboid Gene Against Eimeria Tenella Challenge

Expression and Immunogenicity of Recombinant Mycobacterium Bovis Bacillus Calmette-Guérin Strains Secreting the Antigen ESAT-6 from Mycobacterium Tuberculosis in Mice

Immunogenicity Analysis of a Recombinant BCG Vaccine Strain Overexpressing Rv3478 Protein

Virulence, Immunogenicity, and Protective Efficacy of Two RecombinantMycobacterium Bovisbacillus Calmette-Guérin Strains Expressing the Antigen ESAT-6 Frommycobacterium Tuberculosis

EB virus-positive tumors are inhibited by rBCG expressing hGM-CSF and LMP2A

Evaluation of the Mucosal Immunity Effect of Bovine Viral Diarrhea Virus Subunit Vaccine E2Fc and E2Ft.

Recombinant Bovine Herpesvirus Type I Expressing the Bovine Viral Diarrhea Virus E2 Protein Could Effectively Prevent Infection by Two Viruses

Recombinant BCG vaccine expressing multistage antigens of Mycobacterium tuberculosis provides long-term immunity against tuberculosis in BALB/c mice

The construction of recombinant Lactobacillus casei expressing BVDV E2 protein and its immune response in mice

Recombinant Mycobacterium bovis BCG expressing the chimeric protein of antigen 85B and ESAT-6 enhances the Th1 cell-mediated response.

Enhanced Immune Responses to E2 Protein and DNA Formulated with ISA 61 VG Administered As a DNA Prime–protein Boost Regimen Against Bovine Viral Diarrhea Virus